Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
25 studies found for:    Open Studies | "Graves Disease"
Show Display Options
Rank Status Study
21 Not yet recruiting The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Methylprednisolone + ASTED;   Drug: Methylprednisolone +Placebo
22 Not yet recruiting The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)
Condition: Thyroid Eye Disease
Interventions: Drug: ASTED;   Dietary Supplement: Selenium;   Other: Placebo
23 Recruiting Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues
Condition: Thyroid Associated Ophthalmopathies
Intervention: Drug: bimatoprost 0.03%
24 Recruiting Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Hyaluronic Acid Gel injection;   Drug: Saline injection
25 Recruiting The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy
Conditions: Thyroid-associated Ophthalmopathy;   Dry Eye Syndrome
Interventions: Drug: Methylprednisolone;   Drug: Esomeprazole

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-25) Next Page   
Study has passed its completion date and status has not been verified in more than two years.